Leverage Real-World Data
Exploring the health status from the patient’s perspective in conjugation with collecting biospecimens means you can finally bridge the gap between otherwise disparate data sources to improve decision-making processes and accelerate development. Harmonizing heterogeneous data in research is essential to generate actionable insights, and we can take that data-driven journey with you.
Our community-building approach is patient-centered and allows us to engage with patients over time to create datasets relevant to researchers, patients, providers, regulators, and payers alike.
Data Collection Capabilities
Rethink your study design to include real-world observational data collected in real-time from patient-reported outcome measures, electronic medical record information and history, custom patient surveys and questionnaires, wearable technologies, and long-term follow-up.
- Patient journey
- Patient preference
- Custom surveys and questionnaires
- Quality of life
- Burden of disease
- Impact on individuals
- Impact on families
- Wearable technologies
Medical Records & Laboratory Results
- Family history
- Treatment history
- Natural history
- Clinical genotypes and phenotypes
- Clinical testing
- Decision support tools
The biospecimens we procure are sourced from highly annotated patients who routinely engage with us. We get you the real-world evidence you need to improve the decision-making process earlier in development.
Access to more than 50,000 patients nationwide
Active, long-term patient relationships
Prospectively collected real-world data from patient surveys
Panoramic patient view harmonizes real-world evidence with biospecimen collection
Develop your own patient cohort or registry
Break team silos to increase cross-functional collaboration
We Specialize in These Conditions
Behind our therapeutic experience are patient member communities made up of more than 50,000 total members ready to advance science and medicine for the conditions they live with.
Start a data-driven journey today
Compliance & Quality Assured
Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval of all study protocols, specific study documentation, and study participant facing information. Both Advarra and WCG IRB are organized and operates in compliance with: FDA, OHRP, International Conference on Harmonization (ICH) and Association for the Accreditation of Human Research Protection Programs (AAHRPP).
Sanguine operates under an electronic informed consent process which executes 21 CFR part 11 compliant e-signatures, and Sanguine systems interacting with study participant information are HIPAA-compliant.